GNS Healthcare said this week that it is collaborating with Dana-Farber Cancer Institute and Mount Sinai School of Medicine to build computer models of multiple myeloma using the company’s reverse engineering and forward simulation platform.
The partners will use GNS’ REFS platform to engineer network models from next-generation sequencing data as well as proteomic data, information on patient outcomes, and other clinical data.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
